mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0006 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |